Building a leading one-stop ambulatory cancer center
Luty 2024 — SIAMH has successfully registered the offer document, launched an IPO and raised US$19.5 million.
SIAMH is a one-stop outpatient diagnostics and treatment center for cancer, neurogenerative and cardiovascular diseases in Singapore.
Nasza rola w transakcji
Oaklins’ team in Singapore acted as sponsor, issue manager, underwriter and placement agent in this transaction.
Porozmawiaj z zespołem obsługi transakcji
Powiązane transakcje
Indigo Capital has acquired a minority stake in Vivason
Indigo Capital has acquired a minority stake in Vivason, a leading network of hearing care centers, to support the company’s growth and enable management to increase its ownership stake.
Więcej informacjiUKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Więcej informacjiMedicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Więcej informacji